Clinical Trial Update: Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of Bremelanotide in women with female sexual arousal disorder completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Arousal Disorder

Drugs mentioned

• Bremelanotide (bremelanotide)

Snippet

Sponsor: Palatin Technologies, Inc | Conditions: Sexual Arousal Disorder | Phase 2 | Status: COMPLETED